Skip to content

2030 at other companies

Solventum logo
SolventumSOLV
Tenet Healthcare logo
Tenet HealthcareTHC
Nutex Health Inc. logo
Nutex Health Inc.NUTX
Henry Schein logo
Henry ScheinHSIC

Other financials

Income statement

See full
Revenue$86.3M-1.1%
Gross profit$47.9M+0.5%
Operating income$3.1M-62.5%
Net income$506.0K+10.2%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$35.4M+250%
Total debt$168.5M-1.4%
Total equity$178.7M+7.1%
Total assets$407.5M+4.8%

Cash flow

See full
Operating cash flow$15.5M+168%
CapEx$1.1M+201%
Free cash flow$14.4M+166%

Valuation

See full
Market cap$392.68M+16.7%
Enterprise value$525.72M+5.7%
P/E42.9×
P/S1.1×+0.2×

Profitability

See full
Gross margin53.2%+1.5pp
Operating margin4.5%+0.2pp
Net margin0.9%+0.5pp
FCF margin12.9%+2.2pp

Returns & leverage

See full
Return on equity1.8%+0.9pp
Debt / equity0.9×-0.1×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by TruBridge, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour.

The official record: TruBridge, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about TruBridge, Inc.'s 2030.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TruBridge, Inc.'s 2030?
TruBridge, Inc. (TBRG) reported 2030 of $6.68M in Q1 2026.
How has TruBridge, Inc.'s 2030 changed year-over-year?
TruBridge, Inc.'s 2030 decreased by 33.9% year-over-year, from $10.1M to $6.68M.